Drug development: try and try again.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 25470198)

Published in Nature on December 04, 2014

Authors

Megan Scudellari

Associated clinical trials:

A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection | NCT01829971

A Study of Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular Carcinoma | NCT00554372

Study of Regorafenib After Sorafenib in Patients With Hepatocellular Carcinoma (RESORCE) | NCT01774344

IMC-A12 in Treating Patients With Advanced Liver Cancer | NCT00639509

A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-Line Treatment of Subjects With Unresectable Hepatocellular Carcinoma | NCT01761266

A Randomized Double-blind, Placebo-controlled Japanese Phase III Trial of ARQ 197 in Hepatocellular Carcinoma (HCC) (JET-HCC) | NCT02029157

A Study of LY2157299 in Participants With Advanced Hepatocellular Carcinoma | NCT02178358

Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma | NCT02191878

Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma | NCT01210495

Articles by these authors

The science myths that will not die. Nature (2015) 2.61

Biobank managers bemoan underuse of collected samples. Nat Med (2013) 1.88

The retirement debate: A grand exit. Nature (2015) 1.37

A ballsy search for cancer targets. Nat Med (2011) 1.07

State of denial. Nat Med (2010) 1.03

HPV: Sex, cancer and a virus. Nature (2013) 0.98

Ageing research: Blood to blood. Nature (2015) 0.97

Genomics contest underscores challenges of personalized medicine. Nat Med (2012) 0.83

Drug development: Mix and match. Nature (2015) 0.81

Mouse mash-up. Sci Am (2010) 0.78

How iPS cells changed the world. Nature (2016) 0.78

Pooled studies can raise misleading alarm bells, regulators say. Nat Med (2010) 0.77

Clinical drive prompts pharma and academia to partner up. Nat Med (2011) 0.76

Targeted vaccines against feline dander could be the cat's meow. Nat Med (2012) 0.75

Science and Culture: Dancing with Pythagoras. Proc Natl Acad Sci U S A (2016) 0.75

Inner Workings: DNA for data storage and computing. Proc Natl Acad Sci U S A (2015) 0.75

Vaccine contamination prompts safety review. Nat Med (2010) 0.75

News Feature: Cleaning up the hygiene hypothesis. Proc Natl Acad Sci U S A (2017) 0.75

Big science has a buzzword problem. Nature (2017) 0.75

Are advance market commitments for drugs a real advance? Nat Med (2011) 0.75

With a slip under the tongue, allergy tablets subdue the sniffles. Nat Med (2012) 0.75

Elusive claims data hold promise for healthcare research. Nat Med (2010) 0.75

The sprint to solve coronavirus protein structures - and disarm them with drugs. Nature (2020) 0.75

Gene test kit oversight could prove a mixed blessing for research. Nat Med (2010) 0.75

TARGETing high-risk childhood cancers. Cancer Discov (2012) 0.75

To boost breast cancer research, a center banks on healthy tissue. Nat Med (2010) 0.75

Myriad sues developers of competing breast cancer tests. Nat Med (2013) 0.75

To stay young, kill zombie cells. Nature (2017) 0.75

Getting across the phase III finish line. Cancer Discov (2013) 0.75

The 24-hour, $1,000 genome. Cancer Discov (2012) 0.75

Whistleblower protections for US government scientists flounder. Nat Med (2011) 0.75

With little research training, geriatricians pick clinic over the lab. Nat Med (2013) 0.75

Core Concept: Cryopreservation aims to engineer novel ways to freeze, store, and thaw organs. Proc Natl Acad Sci U S A (2017) 0.75